Definitive Healthcare (NASDAQ:DH) Trading Up 8.3% – Should You Buy?

Definitive Healthcare Corp. (NASDAQ:DH)’s share price was up 8.3% on Tuesday . The company traded as high as $5.15 and last traded at $5.15. Approximately 439,427 shares traded hands during mid-day trading, a decline of 42% from the average daily volume of 755,208 shares. The stock had previously closed at $4.75.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on DH shares. Needham & Company LLC reiterated a “hold” rating on shares of Definitive Healthcare in a research report on Thursday, January 16th. Stephens initiated coverage on Definitive Healthcare in a research note on Friday, December 20th. They issued an “equal weight” rating and a $5.00 price target on the stock. Finally, Barclays reaffirmed an “underweight” rating and issued a $4.00 price objective on shares of Definitive Healthcare in a research note on Monday, January 13th. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $5.72.

Definitive Healthcare Stock Up 8.4 %

The business has a 50-day moving average price of $4.42 and a 200-day moving average price of $4.43. The company has a market capitalization of $594.93 million, a price-to-earnings ratio of -1.66, a price-to-earnings-growth ratio of 3.65 and a beta of 1.44. The company has a quick ratio of 2.49, a current ratio of 2.49 and a debt-to-equity ratio of 0.33.

Definitive Healthcare (NASDAQ:DH) last posted its quarterly earnings results on Thursday, November 7th. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.08 by ($0.03). Definitive Healthcare had a positive return on equity of 1.76% and a negative net margin of 142.38%. The company had revenue of $62.70 million for the quarter, compared to analyst estimates of $61.66 million. During the same quarter in the prior year, the business posted $0.01 earnings per share. As a group, equities analysts anticipate that Definitive Healthcare Corp. will post 0.15 earnings per share for the current fiscal year.

Insider Activity

In other news, insider William Moschella sold 45,000 shares of the business’s stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $4.70, for a total transaction of $211,500.00. Following the transaction, the insider now owns 433,830 shares in the company, valued at approximately $2,039,001. The trade was a 9.40 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 14.84% of the stock is currently owned by insiders.

Institutional Trading of Definitive Healthcare

Several institutional investors have recently modified their holdings of the company. The Manufacturers Life Insurance Company increased its position in shares of Definitive Healthcare by 17.0% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 22,896 shares of the company’s stock worth $125,000 after purchasing an additional 3,332 shares in the last quarter. Principal Financial Group Inc. lifted its position in shares of Definitive Healthcare by 9.7% during the fourth quarter. Principal Financial Group Inc. now owns 43,960 shares of the company’s stock worth $181,000 after purchasing an additional 3,874 shares in the last quarter. Rhumbline Advisers raised its position in Definitive Healthcare by 5.2% in the 4th quarter. Rhumbline Advisers now owns 81,316 shares of the company’s stock worth $334,000 after purchasing an additional 4,034 shares during the last quarter. Glenmede Trust Co. NA raised its position in shares of Definitive Healthcare by 41.1% during the third quarter. Glenmede Trust Co. NA now owns 18,423 shares of the company’s stock worth $82,000 after acquiring an additional 5,362 shares during the last quarter. Finally, Nisa Investment Advisors LLC increased its position in Definitive Healthcare by 3,652.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 6,980 shares of the company’s stock worth $29,000 after purchasing an additional 6,794 shares during the period. Institutional investors and hedge funds own 98.67% of the company’s stock.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.